Dorothy Trefon Capers - Mar 4, 2025 Form 4 Insider Report for Xylem Inc. (XYL)

Role
SVP & General Counsel
Signature
/s/ Mike Nazario, by power of attorney for Dorothy G. Capers
Stock symbol
XYL
Transactions as of
Mar 4, 2025
Transactions value $
$389,878
Form type
4
Date filed
3/6/2025, 04:11 PM
Previous filing
Mar 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XYL Common Stock Options Exercise $683K +7.87K +98.17% $86.76 15.9K Mar 4, 2025 Direct
transaction XYL Common Stock Options Exercise $420K +4.16K +26.18% $101.09 20K Mar 4, 2025 Direct
transaction XYL Common Stock Sale -$1.53M -12K -60.01% $127.26 8.02K Mar 4, 2025 Direct F1
transaction XYL Common Stock Award $181K +1.4K +17.44% $129.67 9.41K Mar 5, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XYL Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -4.16K -66.67% $0.00 2.08K Mar 4, 2025 Common Stock 4.16K $101.09 Direct F3
transaction XYL Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -7.87K -100% $0.00 0 Mar 4, 2025 Common Stock 7.87K $86.76 Direct F4
transaction XYL Non-Qualified Stock Options (Right to buy) Award $636K +4.91K $129.67 4.91K Mar 5, 2025 Common Stock 4.91K $129.67 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 12,026 Shares were executed at a range of prices from $125.25 to $125.35. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
F2 Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 5, 2026, March 5, 2027 and March 5, 2028.
F3 The March 1, 2023 option grant vested 2,079 options on March 1, 2024, 2,079 options on March 1, 2025, and will vest 2,079 options on March 1, 2026.
F4 The March 1, 2022 option grant vested 2,623 options on March 1, 2023, 2,623 options on March 1, 2024, and 2,622 options on March 1, 2025.
F5 Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 5, 2026, March 5, 2027 and March 5, 2028.